Oral adjuvant activity for nasal influenza vaccines caused by combination of two trihydroxy fatty acid stereoisomers from the tuber of Pinellia ternata

International Immunopharmacology

Volumn 10, Issue 6, 2010, Pages 655-661

  Nagai, Takayuki ^a   Shimizu, Yuliko ^a   Shirahata, Tatsuya ^a   Sunazuka, Toshiaki ^a   Kiyohara, Hiroaki ^a   Omura, Satoshi ^a   Yamada, Haruki ^a  

^a KITASATO UNIVERSITY   (Japan)

Author keywords

Influenza vaccine; Mucosal immunity; Oral adjuvant; Pinellic acid; Stereoisomer

Indexed keywords

HYDROXY FATTY ACID; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOLOGICAL ADJUVANT; INFLUENZA VACCINE; PINELLIC ACID; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HISTOPATHOLOGY; INFLAMMATORY INFILTRATE; INFLUENZA; INFLUENZA VACCINATION; LUNG PARENCHYMA; MOUSE; NONHUMAN; PINELLIA; PINELLIA TERNATA; PRIORITY JOURNAL; STEREOISOMERISM; SURVIVAL RATE;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ADMINISTRATION, ORAL; ANIMALS; ANTIBODIES, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; DRUGS, CHINESE HERBAL; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; HYDROXY ACIDS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; LUNG; MICE; MICE, INBRED BALB C; OLEIC ACIDS; PINELLIA; STEREOISOMERISM;

EID: 77951878338     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2010.03.004     Document Type: Article

References (29)

1. Murphy B.R., and Webster R.G. Orthomyxoviruses. In: Fields B.N., Knipe D.M., and Howley P.M. (Eds). Virology. 3rd ed. (1996), Lippincott-Raven Publishers, Philadelphia 1397-1445 Chapter 46
2. Tamura S.-I., Funato H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., et al. Cross-protection against influenza A virus infection by passively transferred respiratory tract IgA antibodies to different hemagglutinin molecules. Eur J Immunol 21 (1991) 1337-1344
3. Waldman R.H., and Ganguly R. Immunity to infection on secretory surfaces. J Infect Dis 130 (1974) 419-440
4. Tamura S.-I., Asanuma H., Ito Y., Hirabayashi Y., Suzuki Y., Nagamine T., et al. Superior cross-protective effect of nasal vaccination to subcutaneous inoculation with influenza HA vaccine. Eur J Immunol 22 (1992) 477-481
5. Tamura S.-I., Ito Y., Asanuma H., Hirabayashi Y., Suzuki Y., Nagamine T., et al. Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. J Immunol 149 (1992) 981-988
6. Elson C.O., and Dertzbaugh M.T. Mucosal adjuvants. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal immunology. 3rd ed (2005), Elsevier Academic Press, San Diego 967-986 Chapter 54
7. Miyamoto T. Treatment of respiratory diseases by Chinese medicine. Asian Med J 35 (1992) 30-36
8. Nagai T., and Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to" and its mode of action. Int J Immunopharmacol 16 (1994) 605-613
9. Nagai T., Urata M., and Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to": effects on aged mice, against subtypes of A viruses and B virus, and therapeutic effect. Immunopharmacol Immunotoxicol 18 (1996) 193-208
10. Nagai T., Kiyohara H., Munakata K., Shirahata T., Sunazuka T., Harigaya Y., et al. Pinellic acid from the tuber of Pinellia ternata Breitenbach as an effective oral adjuvant for nasal influenza vaccine. Int Immunopharmacol 2 (2002) 1183-1193
11. Sunazuka T., Shirahata T., Yoshida K., Yamamoto D., Harigaya Y., Nagai T., et al. Total synthesis of pinellic acid, a potent oral adjuvant for nasal influenza vaccine. Determination of the relative and absolute configuration. Tetrahedron Lett 43 (2002) 1265-1268
12. Shirahata T., Sunazuka T., Yoshida K., Yamamoto D., Harigaya Y., Nagai T., et al. Total synthesis and adjuvant activity of all stereoisomers of pinellic acid. Bioorg Med Chem Lett 13 (2003) 937-941
13. Shirahata T., Sunazuka T., Yoshida K., Yamamoto D., Harigaya Y., Kuwajima I., et al. Total synthesis, elucidation of absolute stereochemistry, and adjuvant activity of trihydroxy fatty acids. Tetrahedron 62 (2006) 9483-9496
14. Davenport F.M., Hennessy A.V., Brandon F.M., Webster R.G., Barrett Jr. C.D., and Lease G.O. Comparisons of serologic and febrile responses in humans to vaccination with influenza A viruses or their hemagglutinations. J Lab Clin Med 65 (1964) 5-13
15. Nagai T., Arai Y., Emori M., Nunome S.Y., Yabe T., Takeda T., et al. Anti-allergic activity of a Kampo (Japanese herbal) medicine "Sho-seiryu-to (Xiao-Qing-Long-Tang)" on airway inflammation in a mouse model. Int Immunopharmacol 4 (2004) 1353-1365
16. Tamura S.-I., Miyata K., Matsuo K., Asanuma H., Takahashi H., Nakajima K., et al. Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. J Immunol 156 (1996) 3892-3900
17. Nagai T., Suzuki Y., Kiyohara H., Susa E., Kato T., Nagamine T., et al. Onjisaponins, from the root of Polygala tenuifolia Willdenow, as effective adjuvants for nasal influenza and diphtheria-pertussis-tetanus vaccines. Vaccine 19 (2001) 4824-4834
18. Sabitha G., Reddy E.V., Bhikshapathi M., and Yadav J.S. Total synthesis of (9S, 12R, 13S)-pinellic acid. Tetrahedron Lett 48 (2007) 313-315
19. Naidu S.V., and Kumar P. Enantioselective synthesis of (-)-pinellic acid. Tetrahedron Lett 48 (2007) 2279-2282
20. Naidu S.V., Gupta P., and Kumar P. Enantioselective syntheses of (-)-pinellic acid, α- and β-dimorphecolic acid. Tetrahedron 63 (2007) 7624-7633
21. Prasad K.R., and Swain B. Stereoselective total synthesis of (+)-pinellic acid from l-(+)-tartalic acid. Tetrahedron: Asymmetry 19 (2008) 1134-1138
22. Sharma A., Mahato S., and Chattopadhyay S. A chemoenzymatic asymmetric synthesis of (9S, 12S, 13S)- and (9S, 12RS, 13S)-pinellic acids. Tetrahedron Lett 50 (2009) 4986-4988
23. Miura A., and Kuwahara S. A concise synthesis of pinellic acid using a cross-metathesis approach. Tetrahedron 65 (2009) 3364-3368
24. Nagai T., and Yamada H. In vivo anti-influenza virus activity of Kampo (Japanese herbal) medicine "Sho-seiryu-to": stimulation of mucosal immune system and effect on allergic pulmonary inflammation model mice. Immunopharmacol Immunotoxicol 20 (1998) 267-281
25. Yamada H., and Nagai T. In vivo antiinfluenza virus activity of Kampo medicine Sho-seiryu-to through mucosal immune system. Methods Find Exp Clin Pharmacol 20 (1998) 185-192
26. Boyaka P.N., McGhee J.R., Czerkinsky C., and Mestecky J. Mucosal vaccines: an overview. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology. 3rd ed. (2005), Elsevier Academic Press, San Diego 855-874 Chapter 47
27. Ishikawa H., Kanamori Y., Hamada H., and Kiyono H. Development and function of organized gut-associated lymphoid tissues. In: Mestecky J., Lamm M.E., Strober W., Bienenstock J., McGhee J.R., and Mayer L. (Eds). Mucosal Immunology. 3rd ed. (2005), Elsevier Academic Press, San Diego 385-405 Chapter 21
28. Kuper C.F., Koornstra P.J., Hameleers D.M.H., Biewenga J., Spit B.J., Duijvestijn A.M., et al. The role of nasopharyngeal lymphoid tissue. Immunol Today 13 (1992) 219-224
29. Ichimiya I., Kawauchi H., Fujiyoshi T., Tanaka T., and Mogi G. Distribution of immunocompetent cells in normal nasal mucosa: comparisons among germ-free, specific pathogen-free and conventional mice. Ann Otol Rhinol Laryngol 100 (1991) 638-642